These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32610626)

  • 1. Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments.
    Çubuk C; Can FE; Peña-Chilet M; Dopazo J
    Cells; 2020 Jun; 9(7):. PubMed ID: 32610626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
    Liu Y; Justilien V; Fields AP; Murray NR
    Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic Signaling Adaptor Proteins.
    Luo LY; Hahn WC
    J Genet Genomics; 2015 Oct; 42(10):521-529. PubMed ID: 26554907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and cancer mix in Madrid.
    Shaw RJ
    EMBO Rep; 2010 Apr; 11(4):249-51. PubMed ID: 20300115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
    Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
    EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific mechanisms of TMEM16A Ca
    Wang H; Zou L; Ma K; Yu J; Wu H; Wei M; Xiao Q
    Mol Cancer; 2017 Sep; 16(1):152. PubMed ID: 28893247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer.
    Alsaab HO; Abdullaev B; Alkhafaji AT; Alawadi AH; Jahlan I; Bahir H; Bisht YS; Alsaalamy A; Jabbar AM; Mustafa YF
    Pathol Res Pract; 2023 Nov; 251():154848. PubMed ID: 37862919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape.
    Falco MM; Peña-Chilet M; Loucera C; Hidalgo MR; Dopazo J
    NAR Cancer; 2020 Jun; 2(2):zcaa011. PubMed ID: 34316686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct molecular etiologies of male and female hepatocellular carcinoma.
    Natri HM; Wilson MA; Buetow KH
    BMC Cancer; 2019 Oct; 19(1):951. PubMed ID: 31615477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial transcriptomics reveal basal sex differences in supraoptic nucleus gene expression of adult rats related to cell signaling and ribosomal pathways.
    Nguyen DH; Duque V; Phillips N; Mecawi AS; Cunningham JT
    Biol Sex Differ; 2023 Oct; 14(1):71. PubMed ID: 37858270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation to oxidative stress, chemoresistance, and cell survival.
    Landriscina M; Maddalena F; Laudiero G; Esposito F
    Antioxid Redox Signal; 2009 Nov; 11(11):2701-16. PubMed ID: 19778285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis identifies interaction patterns between small molecules and pathways.
    Li Y; Li W; Chen X; Jiang H; Sun J; Chen H; Lv S
    Biomed Res Int; 2014; 2014():931825. PubMed ID: 25114931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of non-steroidal anti-inflammatory drug effect within signaling pathways and miRNA-regulation pathways.
    Li J; Mansmann UR
    PLoS One; 2013; 8(8):e72477. PubMed ID: 23967306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.
    Ertel A; Verghese A; Byers SW; Ochs M; Tozeren A
    Mol Cancer; 2006 Nov; 5(1):55. PubMed ID: 17081305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen.
    Huang R; Wallqvist A; Covell DG
    Genomics; 2006 Mar; 87(3):315-28. PubMed ID: 16386875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
    Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
    Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.